Literature DB >> 8134594

Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography.

P M Ruggieri1, N Poulos, T J Masaryk, J S Ross, N A Obuchowski, I A Awad, W E Braun, J Nally, J S Lewin, M T Modic.   

Abstract

PURPOSE: To estimate the prevalence, location, and type of cerebral aneurysms in patients with adult polycystic kidney disease (PCKD) and identify associated risk factors.
MATERIALS AND METHODS: Ninety-three patients with PCKD were screened for aneurysms with spin-echo parenchymal magnetic resonance (MR) imaging and three-dimensional time-of-flight MR angiography. Prevalence was estimated with the calculated proportions of patients who had aneurysms, adjusted for reported sensitivity and specificity of MR angiography.
RESULTS: Thirteen aneurysms, found in 10 patients, were 7 mm or smaller in largest dimension; 11 of these aneurysms were saccular. Intra- and interobserver variabilities were 96%-98%. Conventional arteriograms, obtained in six patients, helped confirm the MR angiographic findings. The best estimates of prevalence of aneurysms were 11.7% in the study group (n = 93) and 25.8% in patients with a family history of aneurysms (n = 6).
CONCLUSION: The prevalence of aneurysms in the study group was greater than in the general population. MR angiography is useful in screening for cerebral aneurysms.

Entities:  

Mesh:

Year:  1994        PMID: 8134594     DOI: 10.1148/radiology.191.1.8134594

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

Review 1.  Neurology and the kidney.

Authors:  D J Burn; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

2.  Is family history an independent risk factor for stroke?

Authors:  M Kubota; A Yamaura; J Ono; T Itani; N Tachi; K Ueda; I Nagata; S Sugimoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 3.  The genetics of intracranial aneurysms.

Authors:  Boris Krischek; Ituro Inoue
Journal:  J Hum Genet       Date:  2006-05-31       Impact factor: 3.172

Review 4.  Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?

Authors:  M N Rozenfeld; S A Ansari; A Shaibani; E J Russell; P Mohan; M C Hurley
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-04       Impact factor: 3.825

5.  Autosomal dominant polycystic kidney disease presenting as subarachnoid hemorrhage.

Authors:  Jeffrey P Kanne; Lee B Talner
Journal:  Emerg Radiol       Date:  2004-12

6.  Endovascular treatment of cerebral aneurysm after renal transplantation in polycystic kidney disease.

Authors:  Zeferino Demartini; Jennyfer Galdino; Gelson L Koppe; Alexandre T Bignelli; Alexandre N Francisco; Luana Am Gatto
Journal:  Interv Neuroradiol       Date:  2018-02-14       Impact factor: 1.610

7.  A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.

Authors:  Dongyan Liu; Connie J Wang; Daniel P Judge; Marc K Halushka; Jie Ni; Jennifer P Habashi; Javid Moslehi; Djahida Bedja; Kathleen L Gabrielson; Hangxue Xu; Feng Qian; David Huso; Harry C Dietz; Gregory G Germino; Terry Watnick
Journal:  J Am Soc Nephrol       Date:  2013-09-26       Impact factor: 10.121

8.  Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Pamela Mettler; Kim Mc Fann; Oleksandra Tkachenko; Xiang-Dong Yan; Robert W Schrier
Journal:  Am J Nephrol       Date:  2012-10-04       Impact factor: 3.754

9.  Autosomal Dominant Polycystic Kidney Disease and Intracranial Aneurysms: Is There an Increased Risk of Treatment?

Authors:  M N Rozenfeld; S A Ansari; P Mohan; A Shaibani; E J Russell; M C Hurley
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

Review 10.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.